Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sanborn

Showing results (821-830 of 996) with videos related to

Pageof 100
Sort By:
Journal of the American Society of Echocardiography : Official Publication of the American Society of Echocardiography|July 5, 2025
Recommendations for the Evaluation of Left Ventricular Diastolic Function by Echocardiography and for Heart Failure With Preserved Ejection Fraction Diagnosis: An Update From the American Society of EchocardiographySherif F Nagueh, Danita Y Sanborn, Jae K Oh, et al.
Journal of the American College of Cardiology|September 14, 2000
Impact of thrombolysis, intra-aortic balloon pump counterpulsation, and their combination in cardiogenic shock complicating acute myocardial infarction: a report from the SHOCK Trial Registry. SHould we emergently revascularize Occluded Coronaries for cardiogenic shocK?T A Sanborn, L A Sleeper, E R Bates, et al.
Journal of the American College of Cardiology|December 6, 2005
Percutaneous mitral valve repair using the edge-to-edge technique: six-month results of the EVEREST Phase I Clinical TrialTed Feldman, Hal S Wasserman, Howard C Herrmann, et al.
Brain : a Journal of Neurology|February 2, 2024
Engineered Wnt7a ligands rescue blood-brain barrier and cognitive deficits in a COVID-19 mouse modelTroy N Trevino, Avital B Fogel, Guliz Otkiran, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|December 27, 2011
Phase I/II trial of custirsen (OGX-011), an inhibitor of clusterin, in combination with a gemcitabine and platinum regimen in patients with previously untreated advanced non-small cell lung cancerJanessa J Laskin, Garth Nicholas, Christopher Lee, et al.
American Heart Journal|May 29, 2001
Percutaneous coronary intervention for cardiogenic shock in the SHOCK Trial RegistryJ G Webb, T A Sanborn, L A Sleeper, et al.
Nature Materials|August 25, 2025
Competition between excitonic insulators and quantum Hall states in correlated electron-hole bilayersRuishi Qi, Qize Li, Zuocheng Zhang, et al.
Psycho-Oncology|September 14, 2002
A pilot study of group exercise training (GET) for women with primary breast cancer: feasibility and health benefitsGregory G Kolden, Timothy J Strauman, Ann Ward, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 4, 2021
Phase I, First-in-Human Study of the Probody Therapeutic CX-2029 in Adults with Advanced Solid Tumor MalignanciesMelissa Johnson, Anthony El-Khoueiry, Navid Hafez, et al.
Journal of Andrology|April 16, 1998
Androgen regulation of the Pem homeodomain gene in mice and rat Sertoli and epididymal cellsK A Sutton, S Maiti, W A Tribley, et al.
Pageof 100

Showing results (821-830 of 996) with videos related to

Sort By:
Pageof 100
Journal of the American Society of Echocardiography : Official Publication of the American Society of Echocardiography|July 5, 2025
Recommendations for the Evaluation of Left Ventricular Diastolic Function by Echocardiography and for Heart Failure With Preserved Ejection Fraction Diagnosis: An Update From the American Society of EchocardiographySherif F Nagueh, Danita Y Sanborn, Jae K Oh, et al.
Journal of the American College of Cardiology|September 14, 2000
Impact of thrombolysis, intra-aortic balloon pump counterpulsation, and their combination in cardiogenic shock complicating acute myocardial infarction: a report from the SHOCK Trial Registry. SHould we emergently revascularize Occluded Coronaries for cardiogenic shocK?T A Sanborn, L A Sleeper, E R Bates, et al.
Journal of the American College of Cardiology|December 6, 2005
Percutaneous mitral valve repair using the edge-to-edge technique: six-month results of the EVEREST Phase I Clinical TrialTed Feldman, Hal S Wasserman, Howard C Herrmann, et al.
Brain : a Journal of Neurology|February 2, 2024
Engineered Wnt7a ligands rescue blood-brain barrier and cognitive deficits in a COVID-19 mouse modelTroy N Trevino, Avital B Fogel, Guliz Otkiran, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|December 27, 2011
Phase I/II trial of custirsen (OGX-011), an inhibitor of clusterin, in combination with a gemcitabine and platinum regimen in patients with previously untreated advanced non-small cell lung cancerJanessa J Laskin, Garth Nicholas, Christopher Lee, et al.
American Heart Journal|May 29, 2001
Percutaneous coronary intervention for cardiogenic shock in the SHOCK Trial RegistryJ G Webb, T A Sanborn, L A Sleeper, et al.
Nature Materials|August 25, 2025
Competition between excitonic insulators and quantum Hall states in correlated electron-hole bilayersRuishi Qi, Qize Li, Zuocheng Zhang, et al.
Psycho-Oncology|September 14, 2002
A pilot study of group exercise training (GET) for women with primary breast cancer: feasibility and health benefitsGregory G Kolden, Timothy J Strauman, Ann Ward, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 4, 2021
Phase I, First-in-Human Study of the Probody Therapeutic CX-2029 in Adults with Advanced Solid Tumor MalignanciesMelissa Johnson, Anthony El-Khoueiry, Navid Hafez, et al.
Journal of Andrology|April 16, 1998
Androgen regulation of the Pem homeodomain gene in mice and rat Sertoli and epididymal cellsK A Sutton, S Maiti, W A Tribley, et al.
Pageof 100